Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A National Longitudinal Study of Metastases-directed Local Ablative Therapy for Patients With Oligometastatic Disease - a Combined Interventional and Observational Trial

NCT06356779 is registered in ClinicalTrials.gov with Gitte Fredberg Persson MD PhD as lead sponsor.

NCT NCT06356779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06356779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A National Longitudinal Study of Metastases-directed Local Ablative Therapy for Patients With Oligometastatic Disease - a Combined Interventional and Observational Trial
Lead sponsor
Gitte Fredberg Persson MD PhD
Phase
Not applicable
Overall status
Recruiting
Start date
April 15, 2024
Completion date
December 31, 2035
Enrollment
1,200 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

ablation techniques, metastases, oligometastatic disease, radiotherapy, stereotactic radiation, surgery